Association of ABO blood group with plasmodium falciparum malaria in Sudanese population

Mohamed, Abdalla; Abdelmotalab, Mohammed; Elbasheir, Mohamed

doi:10.61186/rabms.10.4.340

Volume 10, Issue 4 (11-2024) Journal of Research in Applied and Basic Medical Sciences 2024, 10(4): 340-346 | Back to browse issues page

‎ 10.61186/rabms.10.4.340

Mendeley

Zotero

RefWorks

Mohamed A, Abdelmotalab M, Elbasheir M. Association of ABO blood group with plasmodium falciparum malaria in Sudanese population. Journal of Research in Applied and Basic Medical Sciences 2024; 10 (4) :340-346
URL: http://ijrabms.umsu.ac.ir/article-1-314-en.html

Association of ABO blood group with plasmodium falciparum malaria in Sudanese population

Abdalla Mohamed ^*

, Mohammed Abdelmotalab

, Mohamed Elbasheir

Faculty of Medical Laboratory Science-based , Alzaiem Alazhari University, Sudan , Abdalla77fas@gmail.com

Abstract: (414 Views)

Background & Aims: Malaria is a febrile illness with an incubation period of one week or more. Plasmodium falciparum is responsible for the most severe forms. So, this cross-sectional hospital-based study conducted to determine the association between ABO blood group and Plasmodium falciparum infection.
Materials & Methods: The study was carried out in three different clinics: Rota Clinic, Military Hospital, and Bahri Hospital in Khartoum states, Sudan. The study was conducted from May to August 2017. The sample size investigated was 580 subjects, with 200 subjects found to have a positive malaria infection (80 females and 120 males).
Result: The results of this study revealed an overall infection rate of 34.4%. The prevalence rates reported in Military Hospital, Bahri Hospital, and Rota Clinic were 37.1%, 34.7%, and 28.2%, respectively. The study results showed that the highest prevalence rate (60%) was among males, while rate in females was 40%. The highest prevalence rate (32%) was reported among the age group 16-30 years old, and the lowest rate (13%) was among the age group 1-15 years old. The investigation revealed that the highest prevalence rate (58%) was among the O blood group, and the lowest prevalence rate (8%) was among the AB blood group. High parasitemia was strictly confined to A and B and low parasitemia in O blood group.
Conclusion: Although the results showed relation of the disease with blood group, sex, and age group, further research with more population is necessary to add more information about the role of ABO blood groups in Plasmodium falciparum malaria and to contribute to malaria prevention.

Keywords: Blood Group, Falciparum, Malaria, Plasmodium, Sudan

Full-Text [PDF 235 kb] (120 Downloads)

Type of Study: orginal article | Subject: General

References

1. García MA, Bautista L, Palomino F. Should blood donors be routinely screened for irregular antibodies? Immunohematology 2012;28(2):60-6. [DOI:10.21307/immunohematology-2019-151] [PMID]

2. Chung WY, Gardiner DL, Hyland C, Gatton M, Kemp DJ, Trenholme KR. Enhanced invasion of blood group A1 erythrocytes by Plasmodium falciparum. Mol Biochem Parasitol 2005;144:128-30. [DOI:10.1016/j.molbiopara.2005.08.004] [PMID]

3. Adjei A, Narh-Bana S, Amu A, Kukula V, Nagai RA, Owusu-Agyei S, Oduro A, Macete E, Abdulla S, Halidou T, Sie A. Treatment outcomes in a safety observational study of dihydroartemisinic /piperaquine (Eurartesim®) in the treatment of uncomplicated malaria at public health facilities in four African countries. Malaria J 2016;15(1):1-0. [DOI:10.1186/s12936-016-1099-7] [PMID] [PMCID]

4. Dhangadamajhia G, Hazrab RK, Ranjitb M. Malaria in Odisha and future perspectives. Forest 2015;34(13.0):22-7. [Google Scholar]

5. DA. Cerebral malaria: clinical features, pathophysiology and treatment. Ann Trop Med Parasitol 1997;91(7):875-84. [DOI:10.1080/00034983.1997.11813214] [PMID]

6. Carlson J, Holmquist G, Taylor DW, Perlmann P, Wahlgren M. Antibodies to a histidine-rich protein (PfHRP1) disrupt spontaneously formed Plasmodium falciparum erythrocyte rosettes. Proc Natl Acad Sci USA 1990; 87:2511-5. [DOI:10.1073/pnas.87.7.2511] [PMID] [PMCID]

7. Avictor Hoff brand, Post graduated haematology/ (and other); Amord publisher; page (164198); fourth Edition; USA. 2001. [URL]

8. Hoffbrand V. Pediatric Hematology. John Wiley & Sons; 2008 Apr 15. [Google Books]

9. Afoakwah R, Aubyn E, Prah J, Nwaefuna EK, Boampong JN. Research Article Relative Susceptibilities of ABO Blood Groups to Plasmodium falciparum Malaria in Ghana. Adv Hematol 2016;5368793. http://dx.doi.org/10.1155/2016/5368793 [DOI:10.1155/2016/5368793] [PMID] [PMCID]

10. Seyoum S, Dagne K. ABO and rhesus blood type frequencies in data from hospitals and the Red Cross in Ethiopia. Ethiop Med J 1985;23:1-6. [Google Scholar]

11. Migot-Nabias F, Mombo LE, Luty AJ, Dubois B, Nabias R, Bisseye C, et al. Human genetic factors related to susceptibility to mild malaria in Gabon. Genes Immun 2000;1:435-41. [DOI:10.1038/sj.gene.6363703] [PMID]

12. Fischer PR, Boone P. Short report: severe malaria associated with blood group. Am J Trop Med Hyg 1998;58(1):122-3. [DOI:10.4269/ajtmh.1998.58.122] [PMID]

13. Mousa A, Al-Taiar A, Anstey NM, Badaut C, Barber BE, Bassat Q, Challenger JD, Cunnington AJ, Datta D, Drakeley C, Ghani AC. The impact of delayed treatment of uncomplicated P. falciparum malaria on progression to severe malaria: A systematic review and a pooled multicentre individual-patient meta-analysis. PLoS Med 2020;17(10):e1003359. [DOI:10.1371/journal.pmed.1003359] [PMID] [PMCID]

14. Tekeste Z, Petros B. The ABO blood group and Plasmodium falciparum malaria in Awash, Metehara and Ziway areas, Ethiopia. Malaria J 2010;9(1):1-4. [DOI:10.1186/1475-2875-9-280] [PMID] [PMCID]

15. McQuaid F, Rowe JA. Rosetting revisited: a critical look at the evidence for host erythrocyte receptors in Plasmodium falciparum rosetting. Parasitology 2020;147(1):1-1. [DOI:10.1017/S0031182019001288] [PMID] [PMCID]

16. Zerihun T, Degarege A, Erko B. Association of ABO blood group and Plasmodium falciparum malaria in Dore Bafeno Area, Southern Ethiopia. Asian Pac J Trop Biomed 2011;1(4):289-94. [DOI:10.1016/S2221-1691(11)60045-2] [PMID]